ZWS Q3 Results: What the Data Says Now

Zurn Elkay Water Solutions reported Q3 earnings on October 28, and the question now is whether the positioning that surrounded the print has shifted in any meaningful way.

The short answer from the lending market is: not yet. Short interest finished October 27 at 2.5% of the free float, down 10.1% on the week and near its lowest level in at least a year. That retreat, flagged in the pre-earnings note published earlier today, has continued. Availability is running at 3,409%, meaning lenders hold roughly 34 shares for every one that has been borrowed. Cost to borrow dropped to 0.32% on October 27, a third lower than the week prior and the softest reading in the 30-day window. There is no pressure in the borrow market, and the short score has drifted down to 37.2, its lowest point in the recent history provided, consistent with the picture of shorts unwinding rather than building.

Options positioning echoes the same lean. The put/call ratio is 0.06, close to flat against its 20-day average of 0.07 and well below where it was in September, when the ratio ran above 0.15 for several weeks. Call volume is dominating options flow by a wide margin. The 52-week high on the PCR was 0.97, which makes today's reading look almost entirely unconcerned with downside protection.

The Street remains constructive but measured. The consensus price target is around $57, implying roughly 16% upside from the current $49.15 close. The most recent analyst action came from RBC Capital on October 14, which trimmed its target from $58 to $54 while holding a Sector Perform rating. Before that, Oppenheimer and Barclays both nudged targets higher over the summer, the latter initiating coverage in late June at Overweight with a $59 target. Bulls point to the Q1 organic sales growth of 11%, the 8% EBITDA beat, and the company's specification-driven exposure to education and healthcare construction. Bears flag the dependence on institutional construction budgets that could face deferral, and commodity cost exposure across copper, brass and steel. The PE is 24.6x and EV/EBITDA is 15.5x, both drifting modestly lower over the past 30 days, which reflects the stock's 5% gain over the month running slightly ahead of earnings revisions.

One institutional detail is worth noting. BlackRock held 14.8% of shares as of September 30, adding roughly 540,000 shares in the most recent reporting period. State Street and Invesco both added meaningful positions in the same quarter, with State Street adding 350,000 shares and Invesco adding 320,000. The Vanguard Group filed a 13G/A in March 2026 showing its stake had fallen to zero from a prior 10.1%, while Vanguard Portfolio Management separately filed a new 13G in April at 5.4%. These are passive, 13G-type filings with no activist intent; stakes are as last disclosed and holders crossing below the 5% threshold may not file again. The buyback program remains active, with the remaining authorization up 194% year-on-year as of Q2, and $49.6 million spent on repurchases in that quarter, up 53% on the prior year.

Wikipedia and ORTEX page views for ZWS are running at a z-score of 5.3 against the company's own 90-day history, a sharp spike in retail attention that almost certainly reflects today's earnings release rather than any organic shift in interest. This is attention, not a revenue signal.

The next scheduled earnings event is February 2, 2027. Between now and then, the key variables to watch are whether short interest rebuilds as the post-print dust settles, how the RBC target trim holds up against whatever Q3 guidance said, and whether the gap between the $49 stock price and the $57 consensus target narrows or widens as the Street digests the results.